Liensinine is primarily studied for its potential biological and pharmacological applications. It exhibits anti-arrhythmic properties, making it a subject of interest in cardiovascular research. The compound has been shown to modulate ion channels in cardiac cells, particularly inhibiting calcium and sodium currents, which helps stabilize heart rhythm. This activity suggests its possible use in managing certain types of cardiac arrhythmias. Additionally, liensinine demonstrates anti-inflammatory and antioxidant effects, which may contribute to protective roles in cellular and tissue models under oxidative stress. Research also explores its ability to induce autophagy and apoptosis in cancer cells, indicating potential as an anticancer agent. Studies in vitro and in animal models suggest it may suppress tumor growth, particularly in liver and breast cancer lines. Due to its natural origin and low toxicity profile, liensinine is being investigated as a lead compound for developing new therapeutic agents in oncology and cardiology. However, clinical applications remain under preclinical investigation.